FLGT
Fulgent Genetics, Inc.
FLGT lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
FLGT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Strong |
FLGT's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
FLGT PE Valuation
FLGT has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
FLGT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect FLGT's losses to grow, with revenue growing.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
HIMS has the edge over FLGT on the outlook, with more favorable profitability expectations.
FLGT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.10 | -$1.71 |
| Q2 2026 | -$2.83 | -$1.17 |
| Q1 2026 | -$2.40 | -$1.07 |
| Q4 2025 | -$1.97 | -$0.56 |
| Q3 2025 | -$1.39 | +$4.12 |
| Q2 2025 | -$1.66 | +$3.81 |
| Q1 2025 | -$1.33 | +$4.23 |
| Q4 2024 | -$1.41 | +$4.22 |
FLGT lost $3.10 per share over the past year, and its loss has widened in each of the last four quarters.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
FLGT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $90.4M | +7.5% |
| Q2 2026 | $85.4M | +4.4% |
| Q1 2026 | $71.1M | -3.2% |
| Q4 2025 | $83.3M | +9.3% |
| Q3 2025 | $84.1M | +17% |
| Q2 2025 | $81.8M | +15% |
| Q1 2025 | $73.5M | +14% |
| Q4 2024 | $76.2M | +8.1% |
FLGT's revenue is recovering but still below its 2021 peak: $90M last quarter, up 7.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -25% | -6.7 points |
| Q2 2026 | -42% | -18 points |
| Q1 2026 | -49% | -22 points |
| Q4 2025 | -43% | -22 points |
| Q3 2025 | -18% | +5.5 points |
| Q2 2025 | -24% | +2.5 points |
| Q1 2025 | -27% | +6.8 points |
| Q4 2024 | -21% | +193 points |
FLGT's operating margin was −25% last quarter, down 6.7 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over FLGT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over FLGT on profitability, with a higher operating margin.
FLGT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $107.4M | +2025% |
| Q2 2026 | -$27.6M | +$9.4M |
| Q1 2026 | $1.9M | +$11M |
| Q4 2025 | -$83.1M | -491% |
| Q3 2025 | $5.1M | +$40.1M |
| Q2 2025 | -$37M | -$28.3M |
| Q1 2025 | -$9.1M | -385% |
| Q4 2024 | $21.2M | +80% |
FLGT's free cash flow was −$1M over the past year, against −$20M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over FLGT on cash generation, producing positive trailing cash flow while its opponent burns cash.
FLGT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -343K shares |
| 1 year | -10% | -3.1M shares |
| 3 years | -7.8% | -2.4M shares |
| 5 years | -11% | -3.5M shares |
| Available history | +48% | +9M shares |
FLGT has the edge over HIMS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $251,000 |
| Q2 2026 | $23.8M |
| Q1 2026 | $40.1M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.2M |
| Q1 2025 | $8.7M |
| Q4 2024 | — |
FLGT spent $64M buying back its own shares over the past year, about six times what it spent the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has 234M diluted shares, down 6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
FLGT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -0.4x | Net Cash |
| Q3 2022 | -0.4x | Net Cash |
| Q2 2022 | -0.2x | Net Cash |
| Q1 2022 | -0.6x | Net Cash |
| Q4 2021 | -0.2x | Net Cash |
| Q3 2021 | -0.3x | Net Cash |
| Q2 2021 | -0.1x | Net Cash |
| Q1 2021 | -0.3x | Net Cash |
FLGT has more cash than debt.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
FLGT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.9 | Neutral |
| Stochastic | 79.5 | Neutral |
FLGT's weekly RSI is 65 (neutral) and its Stochastic is 79 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
FLGT PE vs Healthcare Sector
| Metric | FLGT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
FLGT has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
FLGT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.8 | 14% above |
| 20 week MA | $20.6 | 21% above |
| 50 week MA | $20.5 | 22% above |
| 100 week MA | $20.4 | 22% above |
| 200 week MA | $23.7 | 4.9% above |
FLGT has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
FLGT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.2 | $45.8 | +246% |
| 2021 | $45.8 | $100.2 | +119% |
| 2022 | $100.2 | $30.3 | -70% |
| 2023 | $30.3 | $28.9 | -4.7% |
| 2024 | $28.9 | $18.4 | -36% |
| 2025 | $18.4 | $26.7 | +45% |
| 2026 YTD | $26.7 | $24.9 | -7% |
FLGT has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.